Abstract
Binding of bradykinin to bradykinin B2 receptors is the key mediator of hereditary angioedema (HAE) attacks. The duration of action of the bradykinin B2 receptor antagonist icatibant was measured by examining bradykinin-responsive pharmacodynamic (PD) endpoints.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
